Annual report pursuant to section 13 and 15(d)

Note 12 - Restatements

v2.4.0.8
Note 12 - Restatements
12 Months Ended
Dec. 31, 2012
Accounting Changes and Error Corrections [Abstract]  
Accounting Changes and Error Corrections [Text Block]

12. Restatements


Subsequent to filing its Annual Report on Form 10-K for the year ended December 31, 2012 with the SEC on March 11, 2013, the Company determined that it should have used derivative liability accounting to account for the fair value of the warrants issued in the Company’s July PIPE Financing. The Company previously recorded all of the net proceeds from the July PIPE Financing as equity. In recording the net proceeds received, due to the down round provision associated with the exercise price of the warrants, the fair value of the warrants should have been recorded as a derivative liability as of the transaction date with a corresponding decrease to equity. Changes in the fair value of these warrants should have been recognized as other income or expense in the statements of operations.


The Company has calculated the fair value of the warrants issued in the July PIPE Financing at the transaction date and for each relevant reporting period using the Monte Carlo simulation valuation method. The Company has restated its previously issued financial statements to correct the non-cash errors related to derivative liability accounting for warrants issued in the July PIPE Financing.


The impact of the restatements is reflected below for the periods indicated:


   

As of December 31, 2012

   

As of September 30, 2012

 
   

As previously

reported

   

Adjustment

   

Restated

   

As previously

reported

   

Adjustment

   

Restated

 

Balance sheet:

                                               

Total assets

  $ 5,551,746     $ -     $ 5,551,746     $ 7,493,553     $ -     $ 7,493,553  
                                                 

Current liabilities:

                                               

Derivative liabilities

  $ 789     $ 2,128,302     $ 2,129,091     $ 7,439     $ 3,644,458     $ 3,651,897  

All other current liabilities

    4,179,186       -       4,179,186       6,235,291       -       6,235,291  

Total current liabilities

    4,179,975       2,128,302       6,308,277       6,242,730       3,644,458       9,887,188  

All other liabilities

    7,108,872       -       7,108,872       7,028,098       -       7,028,098  

Total liabilities

    11,288,847       2,128,302       13,417,149       13,270,828       3,644,458       16,915,286  

Additional paid-in capital

    60,953,692       (1,957,720 )     58,995,972       60,357,805       (1,957,720 )     58,400,085  

Accumulated deficit

    (65,495,746 )     (170,582 )     (65,666,328 )     (64,937,533 )     (1,686,738 )     (66,624,271 )

Other stockholders' equity

    (1,195,047 )     -       (1,195,047 )     (1,197,547 )     -       (1,197,547 )

Total deficit

    (5,737,101 )     (2,128,302 )     (7,865,403 )     (5,777,275 )     (3,644,458 )     (9,421,733 )

Total liabilities and stockholders' deficit

  $ 5,551,746     $ -     $ 5,551,746     $ 7,493,553     $ -     $ 7,493,553  

   

Year Ended December 31, 2012

   

Three Months Ended September 30, 2012

   

Nine Months Ended September 30, 2012

 
   

As previously

reported

   

Adjustment

   

Restated

   

As previously

reported

   

Adjustment

   

Restated

   

As previously

reported

   

Adjustment

   

Restated

 

Statements of operations:

                                                                       

Operating loss

  $ (3,129,278 )   $ -     $ (3,129,278 )   $ (1,017,039 )   $ -     $ (1,017,039 )   $ (2,648,008 )   $ -     $ (2,648,008 )

Gain (loss) on change in fair value of derivative liabilities

    (789 )     (170,582 )     (171,371 )     19,106       (1,686,738 )     (1,667,632 )     (7,439 )     (1,686,738 )     (1,694,177 )

All other income (expense)

    (2,577,069 )     -       (2,577,069 )     (76,622 )     -       (76,622 )     (2,493,476 )     -       (2,493,476 )

Net Loss

  $ (5,707,136 )   $ (170,582 )   $ (5,877,718 )   $ (1,074,555 )   $ (1,686,738 )   $ (2,761,293 )   $ (5,148,923 )   $ (1,686,738 )   $ (6,835,661 )

Net loss per share (basic and diluted)

  $ (0.14 )   $ (0.01 )   $ (0.15 )   $ (0.02 )   $ (0.04 )   $ (0.06 )   $ (0.14 )   $ (0.04 )   $ (0.18 )

Certain amounts in the related statements of cash flows have been corrected, but those changes do not impact the net cash provided from or used in operating, investing or financing activities.